199 related articles for article (PubMed ID: 9516920)
1. Quantitation of DNA from exfoliated colonocytes isolated from human stool surface as a novel noninvasive screening test for colorectal cancer.
Loktionov A; O'Neill IK; Silvester KR; Cummings JH; Middleton SJ; Miller R
Clin Cancer Res; 1998 Feb; 4(2):337-42. PubMed ID: 9516920
[TBL] [Abstract][Full Text] [Related]
2. [Colorectal exfoliated cell in stool and its nuclear DNA quantitative analysis for diagnosis of colorectal cancer].
Fan RY; Li SR; Wu ZT; Wu X; Chen ZM
Ai Zheng; 2002 Jul; 21(7):776-80. PubMed ID: 12479106
[TBL] [Abstract][Full Text] [Related]
3. Colorectal cancer detection by measuring DNA from exfoliated colonocytes obtained by direct contact with rectal mucosa.
Loktionov A; Bandaletova T; Llewelyn AH; Dion C; Lywood HG; Lywood RC; Rockall TA; Stebbing JF; Broughton M; Caffarey S; Marks CG
Int J Oncol; 2009 Feb; 34(2):301-11. PubMed ID: 19148463
[TBL] [Abstract][Full Text] [Related]
4. New method for colorectal cancer diagnosis based on SSCP analysis of DNA from exfoliated colonocytes in naturally evacuated feces.
Onouchi S; Matsushita H; Moriya Y; Akasu T; Fujita S; Yamamoto S; Hasegawa H; Kitagawa Y; Matsumura Y
Anticancer Res; 2008; 28(1A):145-50. PubMed ID: 18383838
[TBL] [Abstract][Full Text] [Related]
5. Testing of multiple samples increases the sensitivity of stool decay-accelerating factor test for the detection of colorectal cancer.
Mizuno M; Mizuno M; Iwagaki N; Nasu J; Okazaki H; Yamamoto K; Okada H; Tsuji T; Fujita T; Shiratori Y
Am J Gastroenterol; 2003 Nov; 98(11):2550-5. PubMed ID: 14638362
[TBL] [Abstract][Full Text] [Related]
6. Detection of hypermethylated DNA or cyclooxygenase-2 messenger RNA in fecal samples of patients with colorectal cancer or polyps.
Leung WK; To KF; Man EP; Chan MW; Hui AJ; Ng SS; Lau JY; Sung JJ
Am J Gastroenterol; 2007 May; 102(5):1070-6. PubMed ID: 17378912
[TBL] [Abstract][Full Text] [Related]
7. A new method for isolating colonocytes from naturally evacuated feces and its clinical application to colorectal cancer diagnosis.
Matsushita H; Matsumura Y; Moriya Y; Akasu T; Fujita S; Yamamoto S; Onouchi S; Saito N; Sugito M; Ito M; Kozu T; Minowa T; Nomura S; Tsunoda H; Kakizoe T
Gastroenterology; 2005 Dec; 129(6):1918-27. PubMed ID: 16344060
[TBL] [Abstract][Full Text] [Related]
8. Improved fecal DNA test for colorectal cancer screening.
Itzkowitz SH; Jandorf L; Brand R; Rabeneck L; Schroy PC; Sontag S; Johnson D; Skoletsky J; Durkee K; Markowitz S; Shuber A
Clin Gastroenterol Hepatol; 2007 Jan; 5(1):111-7. PubMed ID: 17161655
[TBL] [Abstract][Full Text] [Related]
9. DNA stool test for colorectal cancer: hypermethylation of the secreted frizzled-related protein-1 gene.
Zhang W; Bauer M; Croner RS; Pelz JO; Lodygin D; Hermeking H; Stürzl M; Hohenberger W; Matzel KE
Dis Colon Rectum; 2007 Oct; 50(10):1618-26; discussion 1626-7. PubMed ID: 17762966
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of calgranulin B in stools from the patients with colorectal cancer.
Yoo BC; Shin YK; Lim SB; Hong SH; Jeong SY; Park JG
Dis Colon Rectum; 2008 Nov; 51(11):1703-9. PubMed ID: 18584251
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.
Koga Y; Yasunaga M; Takahashi A; Kuroda J; Moriya Y; Akasu T; Fujita S; Yamamoto S; Baba H; Matsumura Y
Cancer Prev Res (Phila); 2010 Nov; 3(11):1435-42. PubMed ID: 20959518
[TBL] [Abstract][Full Text] [Related]
12. Detection of colorectal cancer by a quantitative fluorescence determination of DNA amplification in stool.
Calistri D; Rengucci C; Lattuneddu A; Francioni G; Polifemo AM; Nanni O; Saragoni L; Monti F; Ravaioli A; Zoli W; Amadori D
Neoplasia; 2004; 6(5):536-40. PubMed ID: 15548362
[TBL] [Abstract][Full Text] [Related]
13. Nucleic acids from intact epithelial cells as a target for stool-based molecular diagnosis of colorectal cancer.
Spethmann S; Fischer C; Wagener C; Streichert T; Tschentscher P
Int J Mol Med; 2004 Mar; 13(3):451-4. PubMed ID: 14767578
[TBL] [Abstract][Full Text] [Related]
14. Microsatellite analysis of fecal DNA for colorectal cancer detection.
Koshiji M; Yonekura Y; Saito T; Yoshioka K
J Surg Oncol; 2002 May; 80(1):34-40. PubMed ID: 11967905
[TBL] [Abstract][Full Text] [Related]
15. [Gene methylation in stool for the screening of colorectal cancer and pre-malignant lesions].
Kang YP; Cao FA; Chang WJ; Lou Z; Wang H; Wu LL; Fu CG; Cao GW
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Jan; 14(1):52-6. PubMed ID: 21271382
[TBL] [Abstract][Full Text] [Related]
16. Frequent detection of K-ras mutation in stool samples of colorectal carcinoma patients after improved DNA extraction: comparison with tissue samples.
Ito Y; Kobayashi S; Taniguchi T; Kainuma O; Hara T; Ochiai T
Int J Oncol; 2002 Jun; 20(6):1263-8. PubMed ID: 12012008
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of different stool tests for the detection of cancer of the colon].
Vogel T; Driemel C; Hauser A; Hansmann A; Lange S; Jonas M; Möslein G
Dtsch Med Wochenschr; 2005 Apr; 130(14):872-7. PubMed ID: 15800820
[TBL] [Abstract][Full Text] [Related]
18. Stool-based DNA tests for colorectal cancer: clinical potential and early results.
Ahlquist DA
Rev Gastroenterol Disord; 2002; 2 Suppl 1():S20-6. PubMed ID: 12439395
[TBL] [Abstract][Full Text] [Related]
19. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
[TBL] [Abstract][Full Text] [Related]
20. Colon cancer screening strategies.
Agrawal J; Syngal S
Curr Opin Gastroenterol; 2005 Jan; 21(1):59-63. PubMed ID: 15687886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]